New trials – MIMS, Scriver’s OMMBID and Future Medicine collection
By Lisa K Flint, on 1 October 2012
UCL has a few new trials for new products, please send any feedback on any of these resources to email@example.com
1) UCL has a trial of MIMS until 30 November 2012.
This trial will give users access to the MIMS drug database. The database includes information on indications, doses, side effects, interactions, contraindications and warnings, and can be searched or browsed.
If you are already registered on GPonline/MIMS, log out and log back in again for access to the drug database. Otherwise, create an account.
2) UCL has a 30-day trial of Scriver’s OMMBID – The Online Metabolic & Molecular Bases of Inherited Disease – starting on 1 October 2012.
The trial is accessible on-site, or off-site using remote WTS.
Scriver’s OMMBID focuses on the molecular and metabolic underpinnings of a growing list of inherited diseases, as well as pathophysiology and treatment.
3) UCL also has a trial of the Future Medicine collection of journals until 31 December 2012. (see below for full list)
The titles included have been added to the ejournals list. They include:
Biomarkers in Medicine
Breast Cancer Management
Imaging in Medicine
International Journal of Clinical Rheumatology
International Journal of Hematologic Oncology
Journal of Comparative Effectiveness Research
Lung Cancer Management
Neurodegenerative Disease Management